.
.
.
.
Coronavirus

French health minister says ordered 50,000 doses of Merck’s COVID-19 antiviral pills

Published: Updated:

France has ordered 50,000 doses of Merck & Co’s experimental COVID-19 antiviral drug for adults, the country’s health minister Olivier Veran told a hearing at the French Senate on Tuesday.

“France positioned itself very early in pre-ordering. France ordered 50,000 doses of the drug,” Veran told lawmakers about molnupiravir, which is Merck & Co’s experimental antiviral pills
to treat COVID-19 ailments.

Read the latest updates in our dedicated coronavirus section.

Governments around the world are preparing to ensure they can cope any pick-up in the COVID virus as the winter season approaches in the northern hemisphere.

For the latest headlines, follow our Google News channel online or via the app.

Merck & Co said on Monday that the European Union’s drug regulator had initiated a real-time review of its experimental COVID antiviral drug for adults.

While vaccines are the main weapons against COVID-19, Merck’s experimental pill molnupiravir could be a game-changer after studies showed it could halve the chances of dying or being hospitalized for those most at risk of contracting severe illness.

Read more:

EU regulator starts real-time review of US drugmaker Merck’s COVID-19 pill

Expo 2020 Dubai: WHO chief urges more COVID-19 vaccine help for poor nations

China locks down Lanzhou, city of 4 million, over COVID-19